MCH has successfully delivered and handed over a brand-new Operating Theatre and Recovery facility to Sulis Hospital, part of Royal United Hospitals Bath NHS Foundation Trust. The new high-specification facility will provide the Trust with additional orthopaedic surgical capacity and will be vital in its battle to reduce the clinical backlog.
The facility delivered was one of the immediately available theatres we prebuilt offsite, in collaboration with our manufacturing partner ModuleCo. The plan was to build several high-specification, standardised operating theatres in advance as opposed to them being built to order. This allowed the theatres to be delivered and installed much quicker since the design and manufacture had already been completed, allowing the installation and commissioning to be completed within a matter of weeks.
This approach appealed to the Trust since it resulted in the facility being operational within a shorter timeframe, allowing the Trust and its patients to benefit from the theatre much earlier.
The facility has been provided on a hired basis for an initial 12-month period, with procurement via the NHS Shared Business Services framework (SBS). This is a significant milestone for MCH with its previous minimum term being 24 months and provides significant benefits to NHS Trusts for the future, as it allows hospitals with immediate and flexible access to fully compliant clinical facilities.
Our Managing Director, Alan Wilson, said: “Sulis Hospital has been a whirlwind of a project because of the pace at which the project has moved. Due to the investment, we provided into the construction of these theatres, the business now has a more flexible rental model, allowing our clients to see the immediate benefits of working in a facility that has been designed and built to permanent standards.
Our immediately available campaign has proved to be extremely successful, and the Sulis Hospital project is a perfect example of how offsite construction can quickly assist the NHS in providing a no-compromise solution to their clinical estate strategy.”
